Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 17, 2025 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at Kidney Week
August 14, 2025 16:20 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results

Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results
August 06, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
July 30, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

Eledon to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at WTC
July 17, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at WTC 2025
June 25, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
May 14, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
March 20, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
March 04, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
February 07, 2025 10:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

Eledon Announces Tegoprubart Use as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human